tiprankstipranks
Trending News
More News >
MEDIQON Group AG (DE:CHG)
:CHG
Germany Market
Advertisement

MEDIQON Group AG (CHG) AI Stock Analysis

Compare
2 Followers

Top Page

DE:CHG

MEDIQON Group AG

(XETRA:CHG)

Rating:45Neutral
Price Target:
€40.00
▲(6.10% Upside)
The overall stock score is primarily influenced by financial performance and technical analysis. Despite strong revenue growth, profitability issues and a negative P/E ratio weigh heavily on the score. Technical indicators suggest bearish momentum, further impacting the stock's attractiveness.

MEDIQON Group AG (CHG) vs. iShares MSCI Germany ETF (EWG)

MEDIQON Group AG Business Overview & Revenue Model

Company DescriptionCHAPTERS Group AG, together with its subsidiaries, provides software solutions in the DACH region. It also provides building cleaning and related services; electronic gate and door systems, as well as barriers, fire, and smoke protection systems; CAD/CAM software solutions; conversation-oriented language courses; communication design degree; pest control services; software solutions to sheet metal processing, property management, property developers, and project development industries, as well as engages in planning, consultation, and construction in the field of refrigeration and air conditioning technology, and air purification. In addition, the company provides software solutions for managing fire brigades, as well as mountain, water, and cave rescues; winKITA software; software for utilities and heating bills for private landlords and property managers; industry solutions for property developers; supplemental alarming solutions for fire brigades, rescue services, and emergency organizations; and corporate and group planning, and business intelligence solutions. Further, it offers enterprise content management software solutions; business management solutions for builders and project developers; solutions for property management companies; orchestra management software; modular software solutions; school administration software; ERP software; broadband networks for municipal utilities, municipalities, and other network owners; technical solutions; and support services for international students and young professionals, as well as imports and distributes cable protection products. Additionally, the company develops and sells software solution for fishing, hunting, and gun license administration; and provides CRM software solution to electricity and gas suppliers, water and energy suppliers, and public service broadcasters. The company was formerly known as MEDIQON Group AG and changed its name to CHAPTERS Group AG in July 2023. CHAPTERS Group AG was founded in 1998 and is based in Hamburg, Germany.
How the Company Makes MoneyMEDIQON Group AG generates revenue through multiple streams, including the sale of medical devices, subscription fees for its digital health applications, and service agreements with healthcare institutions. The company leverages partnerships with hospitals and clinics to integrate its technology into existing healthcare infrastructures, which helps to secure long-term contracts and recurring revenue. Additionally, MEDIQON Group AG may benefit from research and development collaborations with pharmaceutical companies, further diversifying its income sources.

MEDIQON Group AG Financial Statement Overview

Summary
MEDIQON Group AG shows strong revenue growth but struggles with profitability, as indicated by negative net income and EBIT margins. The balance sheet reflects improved leverage, yet ROE remains negative. Cash flow generation is positive, but efficiency metrics are unavailable.
Income Statement
45
Neutral
MEDIQON Group AG has shown strong revenue growth of 27.02% in the latest year, indicating a positive trajectory. However, the company is struggling with profitability, as evidenced by negative net profit and EBIT margins. The gross profit margin has decreased significantly from the previous year, suggesting potential challenges in cost management or pricing strategy.
Balance Sheet
50
Neutral
The company's debt-to-equity ratio has improved over the years, indicating better leverage management. However, the return on equity remains negative, reflecting ongoing challenges in generating profits from shareholders' equity. The equity ratio is stable, suggesting a balanced capital structure.
Cash Flow
55
Neutral
MEDIQON Group AG has achieved positive free cash flow growth, which is a positive sign for liquidity. However, the operating cash flow to net income ratio is not available, limiting insights into cash flow efficiency. The free cash flow to net income ratio is also unavailable, which could provide further clarity on cash generation relative to earnings.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue110.67M70.77M42.07M28.66M1.08M
Gross Profit47.02M20.19M6.84M4.56M402.76K
EBITDA16.35M11.96M4.82M7.16M-1.33M
Net Income-11.47M-4.08M-5.88M-2.27M-2.27M
Balance Sheet
Total Assets353.74M223.95M169.28M103.55M49.81M
Cash, Cash Equivalents and Short-Term Investments58.51M50.84M26.28M11.09M614.04K
Total Debt76.40M69.35M62.09M51.70M37.30M
Total Liabilities128.75M99.87M77.11M61.71M41.55M
Stockholders Equity224.99M126.06M93.76M42.57M10.00M
Cash Flow
Free Cash Flow6.96M3.81M3.67M1.15M-1.76M
Operating Cash Flow11.47M7.37M5.69M2.87M-1.76M
Investing Cash Flow-98.82M-36.34M-53.21M-47.40M-5.21M
Financing Cash Flow89.00M48.15M58.78M47.06M7.22M

MEDIQON Group AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price37.70
Price Trends
50DMA
42.25
Negative
100DMA
40.95
Negative
200DMA
35.13
Positive
Market Momentum
MACD
-1.39
Positive
RSI
34.45
Neutral
STOCH
23.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:CHG, the sentiment is Negative. The current price of 37.7 is below the 20-day moving average (MA) of 39.55, below the 50-day MA of 42.25, and above the 200-day MA of 35.13, indicating a neutral trend. The MACD of -1.39 indicates Positive momentum. The RSI at 34.45 is Neutral, neither overbought nor oversold. The STOCH value of 23.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:CHG.

MEDIQON Group AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$35.83B9.00-10.39%1.87%8.46%-7.85%
45
Neutral
€872.61M-6.54%56.39%-120.79%
€597.06M48.726.72%0.83%
€710.67M38.033.11%
€439.64M11.4015.59%3.08%
€509.86M20.5115.66%1.66%
$812.37M17.7920.97%1.77%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:CHG
MEDIQON Group AG
37.70
13.10
53.25%
GB:0N5I
adesso AG
92.94
36.82
65.61%
GB:0O0F
CANCOM SE
22.60
-3.80
-14.39%
GB:0O2W
GFT Technologies
16.32
-4.24
-20.62%
GB:0W19
DATAGROUP
61.00
22.38
57.95%
NGRRF
Nagarro SE
58.90
-21.24
-26.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025